Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Amrut Ambardekar to Humans

This is a "connection" page, showing publications Amrut Ambardekar has written about Humans.

 
Connection Strength
  
 
 
0.893
  
  1. Ambardekar AV, Thielen SC. Comorbidities in Heart?Failure: Expect and Embrace the Complexity. JACC Heart Fail. 2023 11; 11(11):1504-1506.
    View in: PubMed
    Score: 0.025
  2. Ambardekar AV, El Rafei A. Guideline-Directed Medical Therapy in?Heart?Failure: The Treatment Is Not Worse Than the Disease. JACC Heart Fail. 2023 04; 11(4):437-439.
    View in: PubMed
    Score: 0.024
  3. Ambardekar AV, Fontana M, Maurer MS, Trachtenberg B, Kittleson M. How to Identify Cardiac Amyloidosis Patients Who Might Benefit From Cardiac Transplantation. JACC Heart Fail. 2023 01; 11(1):115-120.
    View in: PubMed
    Score: 0.024
  4. Ambardekar AV, Sailer C. SGLT2 Inhibitors and Blood Pressure in?Heart?Failure: A Misunderstanding of Our Understanding? JACC Heart Fail. 2023 01; 11(1):90-92.
    View in: PubMed
    Score: 0.024
  5. Peters LL, Raymer DS, Pal JD, Ambardekar AV. Association of COVID-19 Vaccination With Risk of COVID-19 Infection, Hospitalization, and Death in Heart Transplant Recipients. JAMA Cardiol. 2022 06 01; 7(6):651-654.
    View in: PubMed
    Score: 0.023
  6. Ambardekar AV, Stratton MS, Weiser-Evans MCM, Moulton KS, McKinsey TA. Reply: Aortic Valve Remodeling in?CF-LVAD: Beyond the Arterial Wall. J Am Coll Cardiol. 2022 03 29; 79(12):e223.
    View in: PubMed
    Score: 0.023
  7. Ambardekar AV, Stratton MS, Dobrinskikh E, Hunter KS, Tatman PD, Lemieux ME, Cleveland JC, Tuder RM, Weiser-Evans MCM, Moulton KS, McKinsey TA. Matrix-Degrading Enzyme Expression and Aortic Fibrosis During Continuous-Flow Left Ventricular Mechanical Support. J Am Coll Cardiol. 2021 11 02; 78(18):1782-1795.
    View in: PubMed
    Score: 0.022
  8. Ambardekar AV, Raymer DS. Reverse Remodeling the Transplanted Heart by Remodeling Immunosuppression? JACC Heart Fail. 2021 04; 9(4):314-316.
    View in: PubMed
    Score: 0.021
  9. Riordan M, Oreschak K, Peters LL, Aquilante CL, Ambardekar AV. Bariatric Surgery Is Associated With Decreased Calcineurin Inhibitor Time in Therapeutic Range After Heart Transplantation. Transplant Proc. 2021 Mar; 53(2):681-685.
    View in: PubMed
    Score: 0.021
  10. Peters LL, Ambardekar AV. An immunosuppression tightrope: Successful heart transplantation after giant cell myocarditis in a patient with HIV complicated by recurrent giant cell myocarditis and Kaposi sarcoma. J Heart Lung Transplant. 2020 12; 39(12):1506-1508.
    View in: PubMed
    Score: 0.020
  11. Ambardekar AV. When You Hear Hoof Beats, Think?of?the?Treatable Zebras. JACC Heart Fail. 2019 11; 7(11):967-969.
    View in: PubMed
    Score: 0.019
  12. Cornwell WK, Tarumi T, Lawley J, Ambardekar AV. CrossTalk opposing view: Blood flow pulsatility in left ventricular assist device patients is not essential to maintain normal brain physiology. J Physiol. 2019 01; 597(2):357-359.
    View in: PubMed
    Score: 0.018
  13. Cornwell WK, Tarumi T, Lawley J, Ambardekar AV. Rebuttal from William K. Cornwell III, Takashi Tarumi, Justin Lawley and Amrut V. Ambardekar. J Physiol. 2019 01; 597(2):363-364.
    View in: PubMed
    Score: 0.018
  14. Ambardekar AV, Kittleson MM, Palardy M, Mountis MM, Forde-McLean RC, DeVore AD, Pamboukian SV, Thibodeau JT, Teuteberg JJ, Cadaret L, Xie R, Taddei-Peters W, Naftel DC, Kirklin JK, Stevenson LW, Stewart GC. Outcomes with ambulatory advanced heart failure from the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) Registry. J Heart Lung Transplant. 2019 04; 38(4):408-417.
    View in: PubMed
    Score: 0.018
  15. Purohit SN, Cornwell WK, Pal JD, Lindenfeld J, Ambardekar AV. Living Without a Pulse: The Vascular Implications of Continuous-Flow Left Ventricular Assist Devices. Circ Heart Fail. 2018 06; 11(6):e004670.
    View in: PubMed
    Score: 0.017
  16. Ambardekar AV, Weiser-Evans MCM, Li M, Purohit SN, Aftab M, Reece TB, Moulton KS. Coronary Artery Remodeling and Fibrosis With Continuous-Flow Left Ventricular Assist Device Support. Circ Heart Fail. 2018 05; 11(5):e004491.
    View in: PubMed
    Score: 0.017
  17. Ambardekar AV, Thibodeau JT, DeVore AD, Kittleson MM, Forde-McLean RC, Palardy M, Mountis MM, Cadaret L, Teuteberg JJ, Pamboukian SV, Xie R, Stevenson LW, Stewart GC. Discordant Perceptions of Prognosis and Treatment Options Between Physicians and Patients With Advanced Heart Failure. JACC Heart Fail. 2017 09; 5(9):663-671.
    View in: PubMed
    Score: 0.016
  18. Jurgens PT, Aquilante CL, Page RL, Ambardekar AV. Perioperative Management of Cardiac Transplant Recipients Undergoing Noncardiac Surgery: Unique Challenges Created by Advancements in Care. Semin Cardiothorac Vasc Anesth. 2017 Sep; 21(3):235-244.
    View in: PubMed
    Score: 0.016
  19. Patel AC, Dodson RB, Cornwell WK, Hunter KS, Cleveland JC, Brieke A, Lindenfeld J, Ambardekar AV. Dynamic Changes in Aortic Vascular Stiffness in Patients Bridged to Transplant?With Continuous-Flow Left?Ventricular Assist Devices. JACC Heart Fail. 2017 06; 5(6):449-459.
    View in: PubMed
    Score: 0.016
  20. Allen LA, Ambardekar AV. Hashing It Out Over Cannabis: Moving Toward a Standard Guideline on Substance Use for Cardiac Transplantation Eligibility That Includes Marijuana. Circ Heart Fail. 2016 07; 9(7).
    View in: PubMed
    Score: 0.015
  21. Breathett K, Allen LA, Ambardekar AV. Patient-centered care for left ventricular assist device therapy: current challenges and future directions. Curr Opin Cardiol. 2016 May; 31(3):313-20.
    View in: PubMed
    Score: 0.015
  22. McIlvennan CK, Babu AN, Brieke A, Ambardekar AV. Concomitant surgical cryoablation for refractory ventricular tachycardia and left ventricular assist device placement: a dual remedy but a recipe for thrombosis? J Cardiothorac Surg. 2016 Apr 11; 11(1):53.
    View in: PubMed
    Score: 0.015
  23. Ambardekar AV, Forde-McLean RC, Kittleson MM, Stewart GC, Palardy M, Thibodeau JT, DeVore AD, Mountis MM, Cadaret L, Teuteberg JJ, Pamboukian SV, Cantor RS, Lindenfeld J. High early event rates in patients with questionable eligibility for advanced heart failure therapies: Results from the Medical Arm of Mechanically Assisted Circulatory Support (Medamacs) Registry. J Heart Lung Transplant. 2016 06; 35(6):722-30.
    View in: PubMed
    Score: 0.015
  24. Ambardekar AV, Hunter KS, Babu AN, Tuder RM, Dodson RB, Lindenfeld J. Changes in Aortic Wall Structure, Composition, and Stiffness With Continuous-Flow Left Ventricular Assist Devices: A Pilot Study. Circ Heart Fail. 2015 Sep; 8(5):944-52.
    View in: PubMed
    Score: 0.014
  25. Ambardekar AV, Alluri N, Patel AC, Lindenfeld J, Dorosz JL. Myocardial strain and strain rate from speckle-tracking echocardiography are unable to differentiate asymptomatic biopsy-proven cellular rejection in the first year after cardiac transplantation. J Am Soc Echocardiogr. 2015 Apr; 28(4):478-85.
    View in: PubMed
    Score: 0.014
  26. Herod JW, Ambardekar AV. Right ventricular systolic and diastolic function as assessed by speckle-tracking echocardiography improve with prolonged isolated left ventricular assist device support. J Card Fail. 2014 Jul; 20(7):498-505.
    View in: PubMed
    Score: 0.013
  27. Marzec LN, Ambardekar AV. Preoperative evaluation and perioperative management of right ventricular failure after left ventricular assist device implantation. Semin Cardiothorac Vasc Anesth. 2013 Dec; 17(4):249-61.
    View in: PubMed
    Score: 0.012
  28. Allen LA, Ambardekar AV. Diff'rent strokes, different folks: advanced heart failure's changing outlook. Circ Heart Fail. 2013 May; 6(3):355-7.
    View in: PubMed
    Score: 0.012
  29. Ambardekar AV, Dorosz JL, Cleveland JC, Lindenfeld J, Buttrick PM. Longitudinal left ventricular structural and functional imaging during full support with continuous-flow ventricular assist devices: a retrospective, preliminary analysis. J Heart Lung Transplant. 2012 Dec; 31(12):1311-3.
    View in: PubMed
    Score: 0.012
  30. Ambardekar AV, Cannon AP, Cleveland JC, Brieke A, Lindenfeld J. Driving with a driveline: a survey of current practice patterns for allowing a patient supported with a left ventricular assist device to drive. J Heart Lung Transplant. 2011 Oct; 30(10):1204-5.
    View in: PubMed
    Score: 0.011
  31. Ambardekar AV, Walker JS, Walker LA, Cleveland JC, Lowes BD, Buttrick PM. Incomplete recovery of myocyte contractile function despite improvement of myocardial architecture with left ventricular assist device support. Circ Heart Fail. 2011 Jul; 4(4):425-32.
    View in: PubMed
    Score: 0.011
  32. Ambardekar AV, Buttrick PM. Reverse remodeling with left ventricular assist devices: a review of clinical, cellular, and molecular effects. Circ Heart Fail. 2011 Mar; 4(2):224-33.
    View in: PubMed
    Score: 0.010
  33. Ambardekar AV, Allen LA, Lindenfeld J, Lowery CM, Cannon AP, Cleveland JC, Brieke A, Sauer WH. Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device. J Heart Lung Transplant. 2010 Jul; 29(7):771-6.
    View in: PubMed
    Score: 0.010
  34. Ambardekar AV, Lowery CM, Allen LA, Cannon AP, Cleveland JC, Lindenfeld J, Brieke A, Sauer WH. Effect of left ventricular assist device placement on preexisting implantable cardioverter-defibrillator leads. J Card Fail. 2010 Apr; 16(4):327-31.
    View in: PubMed
    Score: 0.010
  35. Ambardekar AV, Krantz MJ. Medical images. Flip-flop heart. Mayo Clin Proc. 2010 Jan; 85(1):103.
    View in: PubMed
    Score: 0.010
  36. Ambardekar AV, Fonarow GC, Dai D, Peterson ED, Hernandez AF, Cannon CP, Krantz MJ. Quality of care and in-hospital outcomes in patients with coronary heart disease in rural and urban hospitals (from Get With the Guidelines-Coronary Artery Disease Program). Am J Cardiol. 2010 Jan 15; 105(2):139-43.
    View in: PubMed
    Score: 0.010
  37. Ambardekar AV, Fonarow GC, Hernandez AF, Pan W, Yancy CW, Krantz MJ. Characteristics and in-hospital outcomes for nonadherent patients with heart failure: findings from Get With The Guidelines-Heart Failure (GWTG-HF). Am Heart J. 2009 Oct; 158(4):644-52.
    View in: PubMed
    Score: 0.009
  38. Ambardekar AV, Lowes B, Cleveland JC, Brieke A. Overdrive pacing suppresses ectopy and minimizes left ventricular assist device suction events. Circ Heart Fail. 2009 Sep; 2(5):516-7.
    View in: PubMed
    Score: 0.009
  39. Ambardekar AV, Krantz MJ. The Brugada syndrome: the perfect storm of genetics and environment? Int J Cardiol. 2010 May 14; 141(1):108-9.
    View in: PubMed
    Score: 0.009
  40. Ambardekar AV, Krantz MJ. Case of ventricular noncompaction: the crypts and the blood. Mayo Clin Proc. 2008 Aug; 83(8):866.
    View in: PubMed
    Score: 0.009
  41. Ambardekar AV, Lewkowiez L, Krantz MJ. Mastitis unmasks Brugada syndrome. Int J Cardiol. 2009 Mar 06; 132(3):e94-6.
    View in: PubMed
    Score: 0.008
  42. Suarez-Pierre A, Zakrzewski J, Anigbogu C, Iguidbashian JP, Ziogas IA, Peters LL, Ambardekar AV, Hoffman JR, Reece TB, Cleveland JC, Rove JY. Prolonged travel time to transplantation center is associated with poor outcomes following heart transplantation. Am J Surg. 2024 Feb; 228:279-286.
    View in: PubMed
    Score: 0.006
  43. Drazner MH, Ambardekar AV, Berlacher K, Blumer V, Chatur S, Cheng R, Cheng RK, Grandin EW, Gorodeski EZ, Kataria R, Katz JN, Kittleson MM, Krishnamoorthy A, Lala A, Lenneman AJ, Lohr NL, Margulies KB, Mentz RJ, Reza N, Wilcox J, Youmans QR, Zieroth S, Teerlink JR. The HFSA Advanced Heart Failure and Transplant Cardiology Fellowship Consensus Conference. J Card Fail. 2024 Feb; 30(2):391-398.
    View in: PubMed
    Score: 0.006
  44. Buchanan C, Buchanan C, Riordan M, Byrd J, Schulte M, Kohrt WM, Ambardekar AV, Allen LA, Wolfel G, Lawley J, Levine BD, Cornwell WK. Cardiopulmonary Performance Among?Heart?Failure Patients Before?and?After Left Ventricular Assist?Device?Implantation. JACC Heart Fail. 2024 Jan; 12(1):117-129.
    View in: PubMed
    Score: 0.006
  45. Chrispin J, Merchant FM, Lakdawala NK, Wu KC, Tomaselli GF, Navara R, Torbey E, Ambardekar AV, Kabra R, Arbustini E, Narula J, Guglin M, Albert CM, Chugh SS, Trayanova N, Cheung JW. Risk of Arrhythmic Death in Patients With Nonischemic Cardiomyopathy: JACC Review Topic of the Week. J Am Coll Cardiol. 2023 08 22; 82(8):735-747.
    View in: PubMed
    Score: 0.006
  46. McIlvennan CK, Urra M, Helmkamp L, Messenger JC, Raymer D, Ream KS, Oldemeyer JB, Ambardekar AV, Barnes K, Allen LA. Magnitude of troponin elevation in patients with biomarker evidence of myocardial injury: relative frequency and outcomes in a cohort study across a large healthcare system. BMC Cardiovasc Disord. 2023 03 24; 23(1):151.
    View in: PubMed
    Score: 0.006
  47. Skogestad J, Albert I, Hougen K, Lothe GB, Lunde M, Eken OS, Veras I, Huynh NTT, B?rstad M, Marshall S, Shen X, Louch WE, Robinson EL, Cleveland JC, Ambardekar AV, Schwisow JA, Jonas E, Calejo AI, Morth JP, Task?n K, Melleby AO, Lunde PK, Sjaastad I, Carlson CR, Aronsen JM. Disruption of Phosphodiesterase 3A Binding to SERCA2 Increases SERCA2 Activity and Reduces Mortality in Mice With Chronic Heart Failure. Circulation. 2023 04 18; 147(16):1221-1236.
    View in: PubMed
    Score: 0.006
  48. Kittleson MM, Ruberg FL, Ambardekar AV, Brannagan TH, Cheng RK, Clarke JO, Dember LM, Frantz JG, Hershberger RE, Maurer MS, Nativi-Nicolau J, Sanchorawala V, Sheikh FH. 2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient?With Cardiac Amyloidosis: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023 03 21; 81(11):1076-1126.
    View in: PubMed
    Score: 0.006
  49. Rubino M, Travers JG, Headrick AL, Enyart BT, Lemieux ME, Cavasin MA, Schwisow JA, Hardy EJ, Kaltenbacher KJ, Felisbino MB, Jonas E, Ambardekar AV, Bristow MR, Koch KA, McKinsey TA. Inhibition of Eicosanoid Degradation Mitigates Fibrosis of the Heart. Circ Res. 2023 01 06; 132(1):10-29.
    View in: PubMed
    Score: 0.006
  50. Tsai CW, Rodriguez MX, Van Keuren AM, Phillips CB, Shushunov HM, Lee JE, Garcia AM, Ambardekar AV, Cleveland JC, Reisz JA, Proenza C, Chatfield KC, Tsai MF. Mechanisms and significance of tissue-specific MICU regulation of the mitochondrial calcium uniporter complex. Mol Cell. 2022 10 06; 82(19):3661-3676.e8.
    View in: PubMed
    Score: 0.006
  51. Zhao Y, Riching AS, Knight WE, Chi C, Broadwell LJ, Du Y, Abdel-Hafiz M, Ambardekar AV, Irwin DC, Proenza C, Xu H, Leinwand LA, Walker LA, Woulfe KC, Bristow MR, Buttrick PM, Song K. Cardiomyocyte-Specific Long Noncoding RNA Regulates Alternative Splicing of the Triadin Gene in the Heart. Circulation. 2022 08 30; 146(9):699-714.
    View in: PubMed
    Score: 0.006
  52. Lin YH, Major JL, Liebner T, Hourani Z, Travers JG, Wennersten SA, Haefner KR, Cavasin MA, Wilson CE, Jeong MY, Han Y, Gotthardt M, Ferguson SK, Ambardekar AV, Lam MP, Choudhary C, Granzier HL, Woulfe KC, McKinsey TA. HDAC6 modulates myofibril stiffness and diastolic function of the heart. J Clin Invest. 2022 05 16; 132(10).
    View in: PubMed
    Score: 0.006
  53. Li H, Trager LE, Liu X, Hastings MH, Xiao C, Guerra J, To S, Li G, Yeri A, Rodosthenous R, Silverman MG, Das S, Ambardekar AV, Bristow MR, Gonz?lez-Rosa JM, Rosenzweig A. lncExACT1 and DCHS2 Regulate Physiological and Pathological Cardiac Growth. Circulation. 2022 04 19; 145(16):1218-1233.
    View in: PubMed
    Score: 0.006
  54. Kittleson MM, Ambardekar AV, Stevenson LW, Gilotra NA, Shah P, Ewald GA, Thibodeau JT, Stehlik J, Palardy M, Estep JD, Cascino TM, Baldwin JT, Jeffries N, Khalatbari S, Yosef M, Peters WT, Richards B, Mann DL, Aaronson KD, Stewart GC. An early relook identifies high-risk trajectories in ambulatory advanced heart failure. J Heart Lung Transplant. 2022 01; 41(1):104-112.
    View in: PubMed
    Score: 0.005
  55. Knoepke CE, Chaussee EL, Matlock DD, Thompson JS, McIlvennan CK, Ambardekar AV, Schaffer EM, Khazanie P, Scherer L, Arnold RM, Allen LA. Changes over Time in Patient Stated Values and Treatment Preferences Regarding Aggressive Therapies: Insights from the DECIDE-LVAD Trial. Med Decis Making. 2022 04; 42(3):404-414.
    View in: PubMed
    Score: 0.005
  56. Peters LL, Ambardekar AV, Rosenthal LD, McIlvennan CK. Universal Depression Screen of Ambulatory Heart Transplant Recipients With Referral for Mental Health Intervention: A Quality Improvement Project. J Nurs Care Qual. 2021 Jul-Sep 01; 36(3):236-241.
    View in: PubMed
    Score: 0.005
  57. Oreschak K, Saba LM, Rafaels N, Ambardekar AV, Deininger KM, PageII R, Lindenfeld J, Aquilante CL. Variants in mycophenolate and CMV antiviral drug pharmacokinetic and pharmacodynamic genes and leukopenia in heart transplant recipients. J Heart Lung Transplant. 2021 09; 40(9):917-925.
    View in: PubMed
    Score: 0.005
  58. Knight WE, Cao Y, Lin YH, Chi C, Bai B, Sparagna GC, Zhao Y, Du Y, Londono P, Reisz JA, Brown BC, Taylor MRG, Ambardekar AV, Cleveland JC, McKinsey TA, Jeong MY, Walker LA, Woulfe KC, D'Alessandro A, Chatfield KC, Xu H, Bristow MR, Buttrick PM, Song K. Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes Enables Modeling of Human Hypertrophic Cardiomyopathy. Stem Cell Reports. 2021 03 09; 16(3):519-533.
    View in: PubMed
    Score: 0.005
  59. Lala A, Shah KB, Lanfear DE, Thibodeau JT, Palardy M, Ambardekar AV, McNamara DM, Taddei-Peters WC, Baldwin JT, Jeffries N, Khalatbari S, Spino C, Richards B, Mann DL, Stewart GC, Aaronson KD, Mancini DM. Predictive Value of Cardiopulmonary Exercise Testing Parameters in Ambulatory Advanced Heart?Failure. JACC Heart Fail. 2021 03; 9(3):226-236.
    View in: PubMed
    Score: 0.005
  60. Sailer C, Edelmann H, Buchanan C, Giro P, Babcock M, Swanson C, Spotts M, Schulte M, Pratt-Cordova A, Coe G, Beindorff M, Page RL, Ambardekar AV, Pal JD, Kohrt W, Wolfel E, Lawley JS, Tarumi T, Cornwell WK. Impairments in Blood Pressure Regulation and Cardiac Baroreceptor Sensitivity Among Patients With Heart Failure Supported With Continuous-Flow Left Ventricular Assist Devices. Circ Heart Fail. 2021 01; 14(1):e007448.
    View in: PubMed
    Score: 0.005
  61. Tran T, Muralidhar A, Hunter K, Buchanan C, Coe G, Hieda M, Tompkins C, Zipse M, Spotts MJ, Laing SG, Fosmark K, Hoffman J, Ambardekar AV, Wolfel EE, Lawley J, Levine B, Kohrt WM, Pal J, Cornwell WK. Right ventricular function and cardiopulmonary performance among patients with heart failure supported by durable mechanical circulatory support devices. J Heart Lung Transplant. 2021 02; 40(2):128-137.
    View in: PubMed
    Score: 0.005
  62. Abraham WT, Psotka MA, Fiuzat M, Filippatos G, Lindenfeld J, Mehran R, Ambardekar AV, Carson PE, Jacob R, Januzzi JL, Konstam MA, Krucoff MW, Lewis EF, Piccini JP, Solomon SD, Stockbridge N, Teerlink JR, Unger EF, Zeitler EP, Anker SD, O'Connor CM. Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium. Eur J Heart Fail. 2020 12; 22(12):2175-2186.
    View in: PubMed
    Score: 0.005
  63. Abraham WT, Psotka MA, Fiuzat M, Filippatos G, Lindenfeld J, Mehran R, Ambardekar AV, Carson PE, Jacob R, Januzzi JL, Konstam MA, Krucoff MW, Lewis EF, Piccini JP, Solomon SD, Stockbridge N, Teerlink JR, Unger EF, Zeitler EP, Anker SD, O'Connor CM. Standardized Definitions for Evaluation?of?Heart Failure Therapies: Scientific Expert Panel From the Heart?Failure Collaboratory and Academic Research Consortium. JACC Heart Fail. 2020 12; 8(12):961-972.
    View in: PubMed
    Score: 0.005
  64. Hughes DL, Rice JD, Burton JR, Jin Y, Peterson RA, Ambardekar AV, Pomposelli JJ, Pomfret EA, Kriss MS. Presence of any degree of coronary artery disease among liver transplant candidates is associated with increased rate of post-transplant major adverse cardiac events. Clin Transplant. 2020 11; 34(11):e14077.
    View in: PubMed
    Score: 0.005
  65. Kittleson MM, Maurer MS, Ambardekar AV, Bullock-Palmer RP, Chang PP, Eisen HJ, Nair AP, Nativi-Nicolau J, Ruberg FL. Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association. Circulation. 2020 07 07; 142(1):e7-e22.
    View in: PubMed
    Score: 0.005
  66. Cornwell WK, Tran T, Cerbin L, Coe G, Muralidhar A, Hunter K, Altman N, Ambardekar AV, Tompkins C, Zipse M, Schulte M, O'Gean K, Ostertag M, Hoffman J, Pal JD, Lawley JS, Levine BD, Wolfel E, Kohrt WM, Buttrick P. New insights into resting and exertional right ventricular performance in the healthy heart through real-time pressure-volume analysis. J Physiol. 2020 07; 598(13):2575-2587.
    View in: PubMed
    Score: 0.005
  67. Lee JW, Koeppen M, Seo SW, Bowser JL, Yuan X, Li J, Sibilia M, Ambardekar AV, Zhang X, Eckle T, Yoo SH, Eltzschig HK. Transcription-independent Induction of ERBB1 through Hypoxia-inducible Factor 2A Provides Cardioprotection during Ischemia and Reperfusion. Anesthesiology. 2020 04; 132(4):763-780.
    View in: PubMed
    Score: 0.005
  68. Oreschak K, Wolfel EE, Saba LM, Ambardekar AV, Lindenfeld J, Aquilante CL. Relationship between nocturnal blood pressure patterns and end organ damage and diastolic dysfunction in heart transplant recipients. Clin Transplant. 2020 05; 34(5):e13842.
    View in: PubMed
    Score: 0.005
  69. Haywood ME, Cocciolo A, Porter KF, Dobrinskikh E, Slavov D, Graw SL, Reece TB, Ambardekar AV, Bristow MR, Mestroni L, Taylor MRG. Transcriptome signature of ventricular arrhythmia in dilated cardiomyopathy reveals increased fibrosis and activated TP53. J Mol Cell Cardiol. 2020 02; 139:124-134.
    View in: PubMed
    Score: 0.005
  70. Ali HR, Michel CR, Lin YH, McKinsey TA, Jeong MY, Ambardekar AV, Cleveland JC, Reisdorph R, Reisdorph N, Woulfe KC, Fritz KS. Defining decreased protein succinylation of failing human cardiac myofibrils in ischemic cardiomyopathy. J Mol Cell Cardiol. 2020 01; 138:304-317.
    View in: PubMed
    Score: 0.005
  71. Stehlik J, Mountis M, Haas D, Palardy M, Ambardekar AV, Estep JD, Ewald G, Russell SD, Robinson S, Jorde U, Taddei-Peters WC, Jeffries N, Richards B, Khalatbari S, Spino C, Baldwin JT, Mann D, Stewart GC, Aaronson KD. Quality of life and treatment preference for ventricular assist device therapy in ambulatory advanced heart failure: A report from the REVIVAL study. J Heart Lung Transplant. 2020 01; 39(1):27-36.
    View in: PubMed
    Score: 0.005
  72. Nakano SJ, Walker JS, Walker LA, Li X, Du Y, Miyamoto SD, Sucharov CC, Garcia AM, Mitchell MB, Ambardekar AV, Stauffer BL. Increased myocyte calcium sensitivity in end-stage pediatric dilated cardiomyopathy. Am J Physiol Heart Circ Physiol. 2019 12 01; 317(6):H1221-H1230.
    View in: PubMed
    Score: 0.005
  73. Grady KL, Andrei AC, Shankel T, Chinnock R, Miyamoto SD, Ambardekar AV, Anderson A, Addonizio L, Latif F, Lefkowitz D, Goldberg LR, Hollander SA, Pham M, Van't Hof K, Weissberg-Benchell J, Yancy C, Liu M, Melody N, Pahl E. Pediatric Heart Transplantation: Transitioning to Adult Care (TRANSIT): Feasibility of a Pilot Randomized Controlled Trial. J Card Fail. 2019 Dec; 25(12):948-958.
    View in: PubMed
    Score: 0.005
  74. Cornwell WK, Ambardekar AV, Tran T, Pal JD, Cava L, Lawley J, Tarumi T, Cornwell CL, Aaronson K. Stroke Incidence and Impact of Continuous-Flow Left Ventricular Assist Devices on Cerebrovascular Physiology. Stroke. 2019 02; 50(2):542-548.
    View in: PubMed
    Score: 0.005
  75. Sweet ME, Cocciolo A, Slavov D, Jones KL, Sweet JR, Graw SL, Reece TB, Ambardekar AV, Bristow MR, Mestroni L, Taylor MRG. Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure. BMC Genomics. 2018 Nov 12; 19(1):812.
    View in: PubMed
    Score: 0.004
  76. Myers VD, Gerhard GS, McNamara DM, Tomar D, Madesh M, Kaniper S, Ramsey FV, Fisher SG, Ingersoll RG, Kasch-Semenza L, Wang J, Hanley-Yanez K, Lemster B, Schwisow JA, Ambardekar AV, Degann SH, Bristow MR, Sheppard R, Alexis JD, Tilley DG, Kontos CD, McClung JM, Taylor AL, Yancy CW, Khalili K, Seidman JG, Seidman CE, McTiernan CF, Cheung JY, Feldman AM. Association of Variants in BAG3 With Cardiomyopathy Outcomes in African American Individuals. JAMA Cardiol. 2018 10 01; 3(10):929-938.
    View in: PubMed
    Score: 0.004
  77. Moulton KS, Li M, Strand K, Burgett S, McClatchey P, Tucker R, Furgeson SB, Lu S, Kirkpatrick B, Cleveland JC, Nemenoff RA, Ambardekar AV, Weiser-Evans MC. PTEN deficiency promotes pathological vascular remodeling of human coronary arteries. JCI Insight. 2018 02 22; 3(4).
    View in: PubMed
    Score: 0.004
  78. Jeong MY, Lin YH, Wennersten SA, Demos-Davies KM, Cavasin MA, Mahaffey JH, Monzani V, Saripalli C, Mascagni P, Reece TB, Ambardekar AV, Granzier HL, Dinarello CA, McKinsey TA. Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism. Sci Transl Med. 2018 02 07; 10(427).
    View in: PubMed
    Score: 0.004
  79. Begay RL, Graw SL, Sinagra G, Asimaki A, Rowland TJ, Slavov DB, Gowan K, Jones KL, Brun F, Merlo M, Miani D, Sweet M, Devaraj K, Wartchow EP, Gigli M, Puggia I, Salcedo EE, Garrity DM, Ambardekar AV, Buttrick P, Reece TB, Bristow MR, Saffitz JE, Mestroni L, Taylor MRG. Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated?Cardiomyopathy and Changes in?the Cell-Cell Adhesion Structures. JACC Clin Electrophysiol. 2018 04; 4(4):504-514.
    View in: PubMed
    Score: 0.004
  80. Stewart GC, Ambardekar AV, Kittleson MM. Defining Ambulatory Advanced Heart Failure: MedaMACS and Beyond. Curr Heart Fail Rep. 2017 12; 14(6):498-506.
    View in: PubMed
    Score: 0.004
  81. Grady KL, Hof KV, Andrei AC, Shankel T, Chinnock R, Miyamoto S, Ambardekar AV, Anderson A, Addonizio L, Latif F, Lefkowitz D, Goldberg L, Hollander SA, Pham M, Weissberg-Benchell J, Cool N, Yancy C, Pahl E. Pediatric Heart Transplantation: Transitioning to Adult Care (TRANSIT): Baseline Findings. Pediatr Cardiol. 2018 Feb; 39(2):354-364.
    View in: PubMed
    Score: 0.004
  82. Cobretti MR, Page RL, Linnebur SA, Deininger KM, Ambardekar AV, Lindenfeld J, Aquilante CL. Medication regimen complexity in ambulatory older adults with heart failure. Clin Interv Aging. 2017; 12:679-686.
    View in: PubMed
    Score: 0.004
  83. Hooker JM, Strebl MG, Schroeder FA, Wey HY, Ambardekar AV, McKinsey TA, Schoenberger M. Imaging cardiac SCN5A using the novel F-18 radiotracer radiocaine. Sci Rep. 2017 02 16; 7:42136.
    View in: PubMed
    Score: 0.004
  84. Jurgens PT, Allen LA, Ambardekar AV, McIlvennan CK. Chronic Norovirus Infections in Cardiac Transplant Patients. Prog Transplant. 2017 03; 27(1):69-72.
    View in: PubMed
    Score: 0.004
  85. Bryant BM, Libby AM, Metz KR, Page RL, Ambardekar AV, Lindenfeld J, Aquilante CL. Evaluating Patient-Level Medication Regimen Complexity Over Time in Heart Transplant Recipients. Ann Pharmacother. 2016 11; 50(11):926-934.
    View in: PubMed
    Score: 0.004
  86. Stratton MS, Lin CY, Anand P, Tatman PD, Ferguson BS, Wickers ST, Ambardekar AV, Sucharov CC, Bradner JE, Haldar SM, McKinsey TA. Signal-Dependent Recruitment of BRD4 to Cardiomyocyte Super-Enhancers Is Suppressed by a MicroRNA. Cell Rep. 2016 08 02; 16(5):1366-1378.
    View in: PubMed
    Score: 0.004
  87. Deininger KM, Vu A, Page RL, Ambardekar AV, Lindenfeld J, Aquilante CL. CYP3A pharmacogenetics and tacrolimus disposition in adult heart transplant recipients. Clin Transplant. 2016 09; 30(9):1074-81.
    View in: PubMed
    Score: 0.004
  88. Lindenfeld J, Cleveland JC, Kao DP, White M, Wichman S, Bristow JC, Peterson V, Rodegheri-Brito J, Korst A, Blain-Nelson P, Sederberg J, Hunt SA, Gilbert EM, Ambardekar AV, Minobe W, Port JD, Bristow MR. Sex-related differences in age-associated downregulation of human ventricular myocardial ?1-adrenergic receptors. J Heart Lung Transplant. 2016 Mar; 35(3):352-361.
    View in: PubMed
    Score: 0.004
  89. McIlvennan CK, Magid KH, Ambardekar AV, Thompson JS, Matlock DD, Allen LA. Clinical outcomes after continuous-flow left ventricular assist device: a systematic review. Circ Heart Fail. 2014 Nov; 7(6):1003-13.
    View in: PubMed
    Score: 0.003
  90. McIlvennan CK, Page RL, Ambardekar AV, Brieke A, Lindenfeld J. Activated partial thromboplastin time overestimates anti-coagulation in left ventricular assist device patients. J Heart Lung Transplant. 2014 Dec; 33(12):1312-4.
    View in: PubMed
    Score: 0.003
  91. Allen LA, Ambardekar AV, Devaraj KM, Maleszewski JJ, Wolfel EE. Clinical problem-solving. Missing elements of the history. N Engl J Med. 2014 Feb 06; 370(6):559-66.
    View in: PubMed
    Score: 0.003
  92. Weitzel LB, Ambardekar AV, Brieke A, Cleveland JC, Serkova NJ, Wischmeyer PE, Lowes BD. Left ventricular assist device effects on metabolic substrates in the failing heart. PLoS One. 2013; 8(4):e60292.
    View in: PubMed
    Score: 0.003
  93. Nguyen DT, Heath R, Ambardekar A, Sauer W. Acquired premature ventricular ectopy after cardiac transplantation. J Heart Lung Transplant. 2012 Jul; 31(7):787-8.
    View in: PubMed
    Score: 0.003
  94. Krantz MJ, Ambardekar AV, Kaltenbach L, Hernandez AF, Heidenreich PA, Fonarow GC. Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure). Am J Cardiol. 2011 Jun 15; 107(12):1818-23.
    View in: PubMed
    Score: 0.003
  95. Peterson PN, Ambardekar AV, Jones PG, Krumholz HM, Schelbert E, Spertus JA, Rumsfeld JS, Masoudi FA. Increased mortality among survivors of myocardial infarction with kidney dysfunction: the contribution of gaps in the use of guideline-based therapies. BMC Cardiovasc Disord. 2009 Jul 08; 9:29.
    View in: PubMed
    Score: 0.002
  96. Chu ES, Reid M, Schulz T, Burden M, Mancini D, Ambardekar AV, Keniston A, Albert RK. A structured handoff program for interns. Acad Med. 2009 Mar; 84(3):347-52.
    View in: PubMed
    Score: 0.002
  97. Shah DJ, Diluzio S, Ambardekar AV, Smulevitz B, Smith GL, Nagaraj A, Hamilton AJ, McPherson DD, Rigolin VH. Evaluation of valvular regurgitation severity using digital acquisition of echocardiographic images. J Am Soc Echocardiogr. 2002 Mar; 15(3):241-6.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)